BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 1766673)

  • 1. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
    Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J
    Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
    Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
    Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
    Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
    Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromosome translocations and the activation of C-myc oncogene in mouse plasmacytomas].
    Ohno S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):587-96. PubMed ID: 6424577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "missing" mouse plasmacytoma (MPC) associated translocation T(15;16) occurs repeatedly in new MPC induction systems.
    Wiener F; Silva S; Sugiyama H; Babonits M; Klein G
    Genes Chromosomes Cancer; 1990 May; 2(1):36-43. PubMed ID: 2126192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juxtaposition of human bcl-2 and immunoglobulin lambda light chain gene in chronic lymphocytic leukemia is the result of a reciprocal chromosome translocation between chromosome 18 and 22.
    Adachi M; Tsujimoto Y
    Oncogene; 1989 Sep; 4(9):1073-5. PubMed ID: 2506501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR; Janz S; Potter M
    Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine plasmacytoma with a variant (15;16)(D2/3;B1) translocation that involves the c-myc and lambda light chain gene-carrying chromosomes.
    Sugiyama H; Silva S; Babonits M; Potter M; Klein G; Wiener F
    Cancer Genet Cytogenet; 1990 May; 46(1):93-7. PubMed ID: 2110029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15.
    Silva S; Babonits M; Klein G
    Genes Chromosomes Cancer; 1996 Nov; 17(3):179-84. PubMed ID: 8946197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene.
    Webb E; Adams JM; Cory S
    Nature; 1984 Dec 20-1985 Jan 2; 312(5996):777-9. PubMed ID: 6440031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
    Klein G
    AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents.
    Shaughnessy JD; Owens JD; Wiener F; Hilbert DM; Huppi K; Potter M; Mushinski JF
    Oncogene; 1993 Nov; 8(11):3111-21. PubMed ID: 8414513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
    Ohno S; Migita S; Murakami S
    Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic 2; 18 and 18; 22 translocation in chronic lymphocytic leukemia with juxtaposition of bcl-2 and immunoglobulin light chain genes.
    Tashiro S; Takechi M; Asou H; Takauchi K; Kyo T; Dohy H; Kikuchi M; Kamada N; Tsujimoto Y
    Oncogene; 1992 Mar; 7(3):573-7. PubMed ID: 1549371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target.
    Pear WS; Wahlström G; Nelson SF; Axelson H; Szeles A; Wiener F; Bazin H; Klein G; Sümegi J
    Mol Cell Biol; 1988 Jan; 8(1):441-51. PubMed ID: 3122026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the c-myc, pvt-1 and immunoglobulin kappa genes in relation to the mouse plasmacytoma-associated variant (6;15) translocation breakpoint.
    Banerjee M; Wiener F; Spira J; Babonits M; Nilsson MG; Sumegi J; Klein G
    EMBO J; 1985 Dec; 4(12):3183-8. PubMed ID: 3937724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Ig gene expression by Ig binding factors. Suppression of alpha-H chain and lambda-2-L chain mRNA accumulation in MOPC-315 by IgA-binding factor.
    Roman S; Moore JS; Darby C; Müller S; Hoover RG
    J Immunol; 1988 May; 140(10):3622-30. PubMed ID: 3129498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
    Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
    Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene expression and immunoglobulin synthesis in a North American Burkitt (NAB-2) lymphoma cell line with a 8;22 chromosome translocation.
    Popescu NC; Dahlberg JE; Ablashi DV; Monastier M; Bona CA; DiPaolo JA; Hooper WC; Swan DC
    Oncogene Res; 1990; 5(4):295-303. PubMed ID: 1697668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
    Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
    Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.